F E Ehrlich, J E Haas, W B Kiesewetter. Show Affiliations »
Abstract
Entities: Disease Species
Mesh: See more » Age FactorsChildChild, PreschoolCyclophosphamide/therapeutic useDactinomycin/therapeutic useDrug SynergismExtremitiesFemaleHead and Neck NeoplasmsHumansInfantInfant, NewbornMaleOrbital NeoplasmsPelvic NeoplasmsPrognosisRhabdomyosarcoma/drug therapyRhabdomyosarcoma/mortalityRhabdomyosarcoma/pathologyRhabdomyosarcoma/radiotherapyRhabdomyosarcoma/surgeryRhabdomyosarcoma/therapySex FactorsVincristine/therapeutic use
Substances: See more » DactinomycinVincristineCyclophosphamide
Year: 1971 PMID: 4108254 DOI: 10.1016/0022-3468(71)90381-2
Source DB: PubMed Journal: J Pediatr Surg ISSN: 0022-3468 Impact factor: 2.545